Back to News
Market Impact: 0.3

Validea Detailed Fundamental Analysis

MCKNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechCapital Returns (Dividends / Buybacks)Market Technicals & FlowsInvestor Sentiment & Positioning
Validea Detailed Fundamental Analysis

Validea's guru fundamental report assigned McKesson Corp (MCK), a large-cap growth stock in the Major Drugs industry, a 100% rating from the Pim van Vliet Multi-Factor Investor model. This top score indicates strong interest based on MCK's underlying fundamentals and valuation, aligning with a strategy that emphasizes low volatility stocks for potentially superior risk-adjusted returns.

Analysis

McKesson Corp (MCK) has been assigned a perfect 100% rating by Validea's Multi-Factor Investor model, which emulates the conservative factor strategy of Pim van Vliet. This top-tier score indicates strong quantitative appeal for the large-cap drug company, whose profile aligns with the model's search for low-volatility stocks that have historically delivered superior risk-adjusted returns. According to the strategy's specific criteria, MCK passes on market capitalization and, critically, on its low standard deviation, directly confirming the low-risk characteristic central to the thesis. Interestingly, the stock registers a "NEUTRAL" score for both its "Twelve Minus One Momentum" and "Net Payout Yield." Despite these neutral factors, the model's final rank is a "PASS" with a 100% score, suggesting that the stock's strong defensive attributes and size are the dominant drivers of its appeal within this specific quantitative framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment